Dedalus and LynxCare: partner to innovate Clinical Research and Data Collaboration through Artificial Intelligence (AI)
Dedalus Group and LynxCare, a fast-growing company in Artificial Intelligence (AI)-driven healthcare data solutions, today announced their partnership to expand the value of Medical information of Trials For Care (T4C), from Trial Recruitment to encompass Real-World Evidence (RWE) studies.

Through the collaboration, we are creating a synergistic combination between Trials ForCare (T4C) and LynxCare’s advanced solutions, services leveraging deep data extraction with therapeutic area-specific high precision Natural Language Processing (NLP) for deeper and more actionable insights. Together, we propose a large panel of opportunities for clinicians, hospitals and life science industries meeting their needs for high quality data and insights throughout their value chain.
Trials For Care (T4C) is a data-as-a-service gateway solution, which offers a secure research network over a number of Hospitals and healthcare providers leveraging advanced technologies to make the data accessible and searchable using advanced Artificial Intelligence (AI) and a broad Natural Language Processing (NLP) to empower clinical research and patient care.
The collaboration with LynxCare will take the enrichment of data sets to the next level toward the generation of precision and actionable insights thanks to disease specific data extraction workflows, that have been developed over the years by LynxCare.
The offering will be globally available with an initial focus on Europe and brings together healthcare providers, researchers, and state of the art technologies to create a harmonized, up to date data network enriched with granular data medically relevant.
“Our mission is to bring value to the Healthcare professionals and the Life science industry, by bridging the gap between fragmented hospital data and the growing demand for comprehensive medical information. By unlocking the potential of patient data, our solution enables more precise identification of clinical trial participants, improves the understanding of patient journeys, and fosters advancements in clinical science and biomedical research,” says Jörg Stieg, Head of Analytics Business Unit at Dedalus including Life Sciences solution Trials For Care (T4C).
“Our joint solution based on Artificial Intelligence (AI) and Natural Language Processing (NLP), crafted with medical insights and scientific knowledge, transforms structured and unstructured Electronic Health Record (EHR) data into high definition and up to date picture of the patients’ journey enhancing the depth and precision of a broad range of investigations. We already demonstrated the value and impact of this process across different therapeutic areas, including Immuno-Oncology and demonstrated the value of driving the adoption of interoperable standards to drive broad research collaborations Oncology, Cardiovascular Disease, and more. …Our mission is to support the data-driven transformation of patient treatments and innovation,” says Jeanne Kehren CEO of LynxCare.
Hospitals and Health care providers participating will have access through Trials For Care (T4C) our Trial Recruitment platform, and the broad capabilities of LynxCare: this will boost the ability to work on both prospective and retrospective studies and engage in collaborations across institutions as well as with the life science industries.
We are confident this joint solution is a new definition for quality and relevance for medical data and will foster innovation, for clinicians, health care systems and industry.
"*" indicates required fields